Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
03 Abril 2024 - 7:00AM
Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the
global leader in tubeless insulin pump technology with its Omnipod®
brand of products, today announced plans to release its financial
results for the first quarter of 2024 on May 9, 2024 after the
close of the financial markets. In connection with the release,
management will host a conference call that day at 4:30 p.m.
(Eastern Time).
The link to the live call will be available on the Investor
Relations section of the Company's website at
investors.insulet.com, “Events and Presentations,” and will be
archived for future replay. You may also access the live call by
dialing (888) 770-7129 for domestic callers, or (929) 203-2109 for
international callers, passcode is 5904836.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in
Massachusetts, is an innovative medical device company dedicated to
simplifying life for people with diabetes and other conditions
through its Omnipod product platform. The Omnipod Insulin
Management System provides a unique alternative to traditional
insulin delivery methods. With its simple, wearable design, the
tubeless disposable Pod provides up to three days of non-stop
insulin delivery, without the need to see or handle a needle.
Insulet’s flagship innovation, the Omnipod® 5 Automated Insulin
Delivery System, integrates with a continuous glucose monitor to
manage blood sugar with no multiple daily injections, zero
fingersticks, and can be fully controlled by a compatible personal
smartphone or Omnipod 5 Controller. Insulet also leverages the
unique design of its Pod by tailoring its Omnipod technology
platform for the delivery of non-insulin subcutaneous drugs across
other therapeutic areas. For more information, please visit:
insulet.com and omnipod.com.
©2024 Insulet Corporation. Omnipod is a registered trademark of
Insulet Corporation. All rights reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240403888119/en/
Investor Relations:
Deborah R. Gordon Vice President, Investor Relations (978)
600-7717 dgordon@insulet.com
Media:
Angela Geryak Wiczek Senior Director, Corporate Communications
(978) 932-0611 awiczek@insulet.com
Insulet (NASDAQ:PODD)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Insulet (NASDAQ:PODD)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025